Table 2.
The correlation between miR-7 expression in serum of gastric cancer patients and clinicopathological features.
Clinicopathological features | Total (n = 53) | miR-7 expression in serum | P |
---|---|---|---|
Age (years) | |||
≥ 60 | 29 | 0.419 ± 0.167 | 0.670 |
< 60 | 24 | 0.400 ± 0.152 | |
Gender | |||
Male | 28 | 0.408 ± 0.153 | 0.892 |
Female | 25 | 0.414 ± 0.168 | |
Tumor size (cm) | |||
≥ 3 | 28 | 0.350 ± 0.145 | 0.003 |
< 3 | 25 | 0.478 ± 0.149 | |
Differentiation degree | |||
High | 16 | 0.523 ± 0.157 | <0.001 |
Moderate + poor | 37 | 0.361 ± 0.135 | |
TNM staging | |||
IIIb stage | 34 | 0.445 ± 0.140 | 0.032 |
IV stage | 19 | 0.348 ± 0.176 | |
Lymphatic metastasis | |||
Yes | 39 | 0.371 ± 0.149 | 0.002 |
No | 14 | 0.519 ± 0.139 |